Gracell Biotechnologies (GRCL) Market Cap

Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Beta: -0.345
52W Range: $1.4-10.435
Website: Gracell Biotechnologies

Market Cap Overview

Market Cap

$989.87M

Share Price

$10.25

Shares Outstanding

19.31M


What is Gracell Biotechnologies's Market Cap?

Gracell Biotechnologies's current Market Cap as of today is $989.87M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Gracell Biotechnologies, the market cap is calculated as $10.25 x 19.31M shares = $989.87M.

As a Small Cap company, Gracell Biotechnologies is a smaller company that may offer growth opportunities.

Gracell Biotechnologies Historical Market Cap

$2.00B$2.00B$1.50B$1.50B$1.00B$1.00B$500.00M$500.00M$0.00$0.00Market CapJul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Download SVG
Download PNG
Download CSV

Gracell Biotechnologies Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Gracell Biotechnologies, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00-$3.00B-$3.00BValue20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Gracell Biotechnologies's enterprise value as of September 30, 2023 (Q3 2023) is calculated as:

  • Market Cap: $989.87M
  • Total Debt: $115.82M
  • Cash and Equivalents: $1.68B
  • Enterprise Value: $202.98M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A lower enterprise value indicates a strong net cash position.

Gracell Biotechnologies Annual Market Cap History

Year Market Cap Change
2025 $989.87M -41.95%
2022 $1.71B -32.43%
2021 $2.52B -76.46%
2020 $10.72B 210.22%
2019 $3.46B 1.26%
2018 $3.41B N/A

Frequently Asked Questions

Gracell Biotechnologies's current market capitalization is $989.87M. This makes it a Small Cap company, calculated by multiplying its current stock price of $10.25 by 19.31M outstanding shares.

Gracell Biotechnologies's enterprise value is $202.98M. This is calculated by adding total debt ($115.82M) to market cap and subtracting cash and equivalents ($1.68B). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Gracell Biotechnologies has 19.31M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Gracell Biotechnologies is classified as a Small Cap company. Small-cap companies are smaller companies with market caps between $300 million and $2 billion.

Gracell Biotechnologies's market cap is calculated by multiplying its current stock price ($10.25) by its total number of outstanding shares (19.31M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for GRCL.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio